Agile Therapeutics announces pricing of initial public offering
27/05/2014 15:24
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced the pricing of its initial public offering of 9,166,667 shares of its common stock at a public offering price of USD 6 per share. Agile Therapeutics has granted the underwriters a 30-day option to purchase up to an aggregate of 1,375,000 additional shares of common stock at the initial public offering price to cover any over-allotments. The shares are expected to begin trading on the NASDAQ Global Market, beginning on May 23, 2014, under the symbol "AGRX." The offering is expected to close on May 29, 2014, subject to customary closing conditions. The joint book-running managers for the offering are RBC Capital Markets, LLC and William Blair & Company, L.L.C. In addition, Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are acting as co-managers.
27/05/2014 15:24
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced the pricing of its initial public offering of 9,166,667 shares of its common stock at a public offering price of USD 6 per share. Agile Therapeutics has granted the underwriters a 30-day option to purchase up to an aggregate of 1,375,000 additional shares of common stock at the initial public offering price to cover any over-allotments. The shares are expected to begin trading on the NASDAQ Global Market, beginning on May 23, 2014, under the symbol "AGRX." The offering is expected to close on May 29, 2014, subject to customary closing conditions. The joint book-running managers for the offering are RBC Capital Markets, LLC and William Blair & Company, L.L.C. In addition, Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are acting as co-managers.
